Bridgeworth, LLC Bristol Myers Squibb CO Transaction History

Bridgeworth, LLC

$1.01 Billion
Q4 2023

A detailed history of Bridgeworth, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bridgeworth, LLC holds 4,636 shares of BMY stock, worth $246,588. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,636

Previous 4,815 3.72%

Holding current value

$246,588

Previous $279,000 15.05%

% of portfolio

0.02%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $8,677 - $10,355	-179 Reduced 3.72%	4,636 $237,000
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $26,821 - $29,781	-421 Reduced 8.04%	4,815 $307,000
Q1 2023 Apr 19, 2023	SELL	$65.71 - $74.53 $4,205 - $4,769	-64 Reduced 1.21%	5,236 $362,000
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $42,594 - $50,437	-622 Reduced 10.5%	5,300 $381,000
Q3 2022 Oct 28, 2022	BUY	$0.13 - $76.84 $0 - $153	2 Added 0.03%	5,922 $421,000
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $3,267 - $3,599	-45 Reduced 0.75%	5,920 $456,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $39,285 - $47,107	-639 Reduced 9.68%	5,965 $436,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $36,307 - $42,326	677 Added 11.42%	6,604 $412,000
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $12,662 - $14,832	-214 Reduced 3.48%	5,927 $351,000
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $118,991 - $129,581	1,922 Added 45.56%	6,141 $410,000
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $59 - $66	1 Added 0.02%	4,219 $266,000
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $10,277 - $11,646	178 Added 4.41%	4,218 $262,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $344 - $381	6 Added 0.15%	4,040 $244,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $164 - $192	-3 Reduced 0.07%	4,034 $237,000
Q1 2020 Apr 27, 2020	BUY	$46.4 - $67.43 $278 - $404	6 Added 0.15%	4,037 $225,000
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $198,365 - $258,749	4,031 New	4,031 $259,000
Q3 2019 Oct 15, 2019	SELL	$42.77 - $50.71 $191,524 - $227,079	-4,478 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$44.62 - $49.34 $3,569 - $3,947	80 Added 1.82%	4,478 $203,000
Q1 2019 Apr 24, 2019	BUY	$45.12 - $53.8 $198,437 - $236,612	4,398 New	4,398 $210,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $204,596 - $265,313	-4,196 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $46,414 - $52,352	841 Added 25.07%	4,196 $209,000
Q2 2018 Aug 15, 2018	SELL	$50.53 - $62.98 $41,181 - $51,328	-815 Reduced 19.54%	3,355 $185,000
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $249,866 - $287,646	4,170 New	4,170 $259,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeworth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeworth, LLC with notifications on news.

Account